glp-1 drugs companies Market Overview: Agonists and the Obesity Market | Blog The Next Big Weight Loss
Description
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide
GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.
Experts say theres no evidence GLP-1s can be absorbed through the skin and these patches dont contain the FDA-approved medicine anyway.
Choosing between Mounjaro and Wegovy
